Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Kranse

Showing results (11-20 of 40) with videos related to

Pageof 4
Sort By:
The Journal of Urology|July 1, 1995
Dependence of male voiding efficiency on age, bladder contractility and urethral resistance: development of a voiding efficiency nomogramJ L Bosch, R Kranse, R van Mastrigt, et al.
Urology|June 1, 1997
Complications of transrectal ultrasound-guided systematic sextant biopsies of the prostate: evaluation of complication rates and risk factors within a population-based screening programJ B Rietbergen, A E Kruger, R Kranse, et al.
Urology|December 1, 1995
The value of screening tests in the detection of prostate cancer. Part II: Retrospective analysis of free/total prostate-specific analysis ratio, age-specific reference ranges, and PSA densityC H Bangma, R Kranse, B G Blijenberg, et al.
The Journal of Urology|February 1, 1997
The free-to-total serum prostate specific antigen ratio for staging prostate carcinomaC H Bangma, R Kranse, B G Blijenberg, et al.
The Prostate|April 15, 2008
The interobserver variability of digital rectal examination in a large randomized trial for the screening of prostate cancerC Gosselaar, R Kranse, M J Roobol, et al.
Urology|February 20, 2004
Prostate-specific antigen velocity at low prostate-specific antigen levels as screening tool for prostate cancer: results of second screening round of ERSPC (ROTTERDAM)M J Roobol, R Kranse, H J de Koning, et al.
British Journal of Urology|February 1, 1997
Tumour control according to pathological variables in patients treated by radical prostatectomy for clinically localized carcinoma of the prostateD van den Ouden, W C Hop, R Kranse, et al.
The Prostate|May 27, 1999
Predictors for biopsy outcome in the European Randomized Study of Screening for Prostate Cancer (Rotterdam region)R Kranse, P Beemsterboer, J Rietbergen, et al.
American Journal of Clinical Pathology|March 8, 2000
Quantitative analysis of the decay of immunoreactivity in stored prostate needle biopsy sectionsA N Vis, R Kranse, A L Nigg, et al.
European Journal of Clinical Chemistry and Clinical Biochemistry : Journal of the Forum of European Clinical Chemistry Societies|February 1, 1997
Analytical evaluation of the new Prostatus PSA Free/Total assay for prostate-specific antigen as part of a screening study for prostate cancerB G Blijenberg, C H Bangma, R Kranse, et al.
Pageof 4

Showing results (11-20 of 40) with videos related to

Sort By:
Pageof 4
The Journal of Urology|July 1, 1995
Dependence of male voiding efficiency on age, bladder contractility and urethral resistance: development of a voiding efficiency nomogramJ L Bosch, R Kranse, R van Mastrigt, et al.
Urology|June 1, 1997
Complications of transrectal ultrasound-guided systematic sextant biopsies of the prostate: evaluation of complication rates and risk factors within a population-based screening programJ B Rietbergen, A E Kruger, R Kranse, et al.
Urology|December 1, 1995
The value of screening tests in the detection of prostate cancer. Part II: Retrospective analysis of free/total prostate-specific analysis ratio, age-specific reference ranges, and PSA densityC H Bangma, R Kranse, B G Blijenberg, et al.
The Journal of Urology|February 1, 1997
The free-to-total serum prostate specific antigen ratio for staging prostate carcinomaC H Bangma, R Kranse, B G Blijenberg, et al.
The Prostate|April 15, 2008
The interobserver variability of digital rectal examination in a large randomized trial for the screening of prostate cancerC Gosselaar, R Kranse, M J Roobol, et al.
Urology|February 20, 2004
Prostate-specific antigen velocity at low prostate-specific antigen levels as screening tool for prostate cancer: results of second screening round of ERSPC (ROTTERDAM)M J Roobol, R Kranse, H J de Koning, et al.
British Journal of Urology|February 1, 1997
Tumour control according to pathological variables in patients treated by radical prostatectomy for clinically localized carcinoma of the prostateD van den Ouden, W C Hop, R Kranse, et al.
The Prostate|May 27, 1999
Predictors for biopsy outcome in the European Randomized Study of Screening for Prostate Cancer (Rotterdam region)R Kranse, P Beemsterboer, J Rietbergen, et al.
American Journal of Clinical Pathology|March 8, 2000
Quantitative analysis of the decay of immunoreactivity in stored prostate needle biopsy sectionsA N Vis, R Kranse, A L Nigg, et al.
European Journal of Clinical Chemistry and Clinical Biochemistry : Journal of the Forum of European Clinical Chemistry Societies|February 1, 1997
Analytical evaluation of the new Prostatus PSA Free/Total assay for prostate-specific antigen as part of a screening study for prostate cancerB G Blijenberg, C H Bangma, R Kranse, et al.
Pageof 4